Document is current
Any future updates will be listed below
-
Authors
Dash, Alexander S.
Hind, Karen
Hans, Didier
Nieves, Jeri
Cosman, Felicia https://orcid.org/0000-0003-4554-6616
-
Funding
Funding for this research was provided by:
Amgen
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 25 May 2025
Accepted: 8 September 2025
First Online: 20 September 2025
Declarations
:
: Dr. Dash declares no competing financial interests. Dr. Hind has a relationship with Medimaps Group (consultant or advisory fees). Dr. Hans is the owner of the TBS patent and has a relationship with Medimaps Group (CEO, equity or stocks, board membership). Dr. Nieves reports relationships with Radius Health Inc (funding grants). Dr. Cosman has relationships with Radius Health Inc (consultant or advisory fees, speaker fees), Amgen Inc. (consultant or advisory fees, speaker fees), EnteraBio Ltd (consultant or advisory fees), CuraTeQ Biologics (consultant or advisory fees), Theramex (consultant or advisory fees), and UCB Inc. (consultant or advisory fees).
